Subscribe Latest Edition
Columnists

Brandon Hoffman, BA

Brandon Hoffman is the market development executive for the American Acupuncture Council (AAC). He graduated from Arizona State University with a BA in Business and received a certificate in international business.

Previous Articles

The WHO’s Growing Focus on AI: Why Acupuncturists Should Pay Attention
November 1, 2024 (Vol. 25, Issue 11)
A Collaborative Journey to Better Patient Outcomes: Critical Tools
October 2023 (Vol. 24, Issue 10)
The Power of Effective Communication
June 2023 (Vol. 24, Issue 06)
Trending
Your Practice / Business
Integration of Artificial Intelligence and Data Analytics in Acupuncture
Integration of Artificial Intelligence and Data Analytics in Acupuncture

Acupuncture, a key pillar of traditional Chinese medicine (TCM), has been practiced for thousands of years to promote healing and restore balance within the body. However, with rapid technological advancements reshaping health care, acupuncture is entering a new era. The integration of artificial intelligence (AI) and data analytics is revolutionizing diagnostics, treatment precision, education, and research – enhancing patient outcomes like never before.

Aram Akopyan, MD, LAc
Acupuncture & Acupressure
Acupuncture and Neuroplasticity: A Promising Treatment for PTSD
Acupuncture and Neuroplasticity: A Promising Treatment for PTSD

Interestingly, although lots of attention has recently been given to the role psychedelic medicines employed in therapy could play in healing PTSD and trauma generally, new research has just been published showing acupuncture can also be of significant help in alleviating this widespread disorder, and may act similarly to psychedelics on a particular quality of our brains to heal and remodel themselves: neuroplasticity.

 |  Digital Exclusive
Benjamin Hawes, DAcCHM, LAc, Dipl. OM
Chronic / Acute Conditions
The Emerging Role of Nicotine in the Integrative Treatment of Long COVID
The Emerging Role of Nicotine in the Integrative Treatment of Long COVID

Long COVID has challenged conventional medical paradigms. There is certainly a growing need for therapies that bridge traditional pharmacology with integrative strategies. Among the more unconventional options, nicotine – delivered via low-dose transdermal patches – has surfaced as a potential tool. While the idea may sound wacky, emerging evidence and clinical anecdotes suggest it warrants exploration.

Bill Reddy, LAc, Dipl. Ac.